45854EGP
- Active ingredient
- talazoparib
- Strength
- 0.25mg
- Form
- capsule
- Manufacturer
- pfizer biopharmaceuticals
- Route
- oral.solid
Uses
Antineoplastic agent used in selected patients with BRCA-mutated cancers.
Do not use if
Hypersensitivity to talazoparib or formulation components.
Side effects
Anemia, fatigue, nausea, thrombocytopenia, and neutropenia may occur.
Warnings
Monitor blood counts regularly during treatment.
How it works
PARP inhibitor that interferes with DNA repair in susceptible tumor cells.
Storage
Store at room temperature.